跳转至内容
Merck
CN
所有图片(3)

主要文件

查看所有文档

335681

Sigma-Aldrich

乙二醇二甲基丙烯酸酯

98%, cross-linking reagent polymerization reactions, methacrylate, 90-110 ppm monomethyl ether hydroquinone as inhibitor

别名:

2-甲基-2-丙烯酸-1,2-乙二醇酯, 二甲基丙烯酸乙二醇酯

登录查看公司和协议定价
所有图片(3)

About This Item

线性分子式:
CH2=C(CH3)COOCH2CH2OCOC(CH3)=CH2
CAS号:
97-90-5
分子量:
198.22
Beilstein:
1776663
EC 号:
202-617-2
MDL编号:
MFCD00008590
UNSPSC代码:
12162002
PubChem化学物质编号:
24860340
NACRES:
NA.23

产品名称

乙二醇二甲基丙烯酸酯, 98%, contains 90-110 ppm monomethyl ether hydroquinone as inhibitor

蒸汽密度

>1 (vs air)

质量水平

300

蒸汽压

<0.1 mmHg ( 21.1 °C)

方案

98%

表单

liquid

包含

90-110 ppm monomethyl ether hydroquinone as inhibitor

反应适用性

reagent type: cross-linking reagent
reaction type: Polymerization Reactions

折射率

n20/D 1.454 (lit.)

沸点

98-100 °C/5 mmHg (lit.)

密度

1.051 g/mL at 25 °C (lit.)

Ω端

methacrylate

α端

methacrylate

聚合物结构设计

shape: linear
functionality: homobifunctional

储存温度

2-8°C

SMILES字符串

CC(=C)C(=O)OCCOC(=O)C(C)=C

InChI

1S/C10H14O4/c1-7(2)9(11)13-5-6-14-10(12)8(3)4/h1,3,5-6H2,2,4H3

InChI key

STVZJERGLQHEKB-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

一般描述

乙二醇二甲基丙烯酸酯（EGDMA）是通过两份的甲基丙烯酸和一份的乙二醇缩合而成的一种二酯。

应用

乙二醇二甲基丙烯酸酯可作为交联剂用于制备：

  • 三元共聚体系，聚（丙烯腈-co-乙二醇二甲基丙烯酸酯-co-乙烯基苄基氯），此聚合物可用于药物吸附的吸附剂。
  • 基于PVA（聚乙烯醇）的水凝胶，此聚合物通过自由基共聚反应合成。这些PVA高分子网状结构可用于药物传递系统。
它还可作为聚合物单体，用于通过悬浮聚合制备可膨胀和不可膨胀的聚（乙二醇二甲基丙烯酸酯/丙烯酸）共聚物微球

象形图

Exclamation mark
GHS07

警示用语：

Warning

危险声明

H317,H335

危险分类

Skin Sens. 1 - STOT SE 3

靶器官

Respiratory system

储存分类代码

10 - Combustible liquids

WGK

WGK 1

闪点(°F)

219.2 °F - Pensky-Martens closed cup

闪点(°C)

104 °C - Pensky-Martens closed cup

个人防护装备

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
MKCT6421
MKCP1251
MKCW6121
MKCW9687
MKCS2934

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Robert H Utama et al.
Chemical communications (Cambridge, England), 48(90), 11103-11105 (2012-10-09)
Hollow polymeric nanoparticles with a hydrophilic liquid core have been synthesized in a one-pot approach via a novel inverse miniemulsion periphery RAFT polymerization process. Successful encapsulation and release of a model protein is reported as a potential application.
Andreia F R Pimenta et al.
PloS one, 11(12), e0167728-e0167728 (2016-12-10)
The study of ocular drug delivery systems has been one of the most covered topics in drug delivery research. One potential drug carrier solution is the use of materials that are already commercially available in ophthalmic lenses for the correction
Mariane Gonçalves Santos et al.
Talanta, 163, 8-16 (2016-11-26)
The use of a new class of hybrid materials, called restricted access molecularly imprinted polymers (RAMIPs) seems to present a good strategy for the sample preparation of complex matrices, since these materials combine good protein elimination capacity with high degree
Zhen Wang et al.
Electrophoresis, 33(21), 3151-3158 (2012-09-06)
A microfluidic device that performs "in space" sample fractionation, collection, and preconcentration for proteomics is described. Effluents from a 2.75 mm long fractionation channel, focused via sheath flow, were sequentially delivered into an array of 36-collection channels containing monolithic polymer
Xinglin Lu et al.
Proceedings of the National Academy of Sciences of the United States of America, 114(46), E9793-E9801 (2017-10-29)
The cytotoxicity of 2D graphene-based nanomaterials (GBNs) is highly important for engineered applications and environmental health. However, the isotropic orientation of GBNs, most notably graphene oxide (GO), in previous experimental studies obscured the interpretation of cytotoxic contributions of nanosheet edges.
查看所有相关文献

商品

Continuous Flow Monomer Synthesis

Monomers for ophthalmic use aim for purity, reliability, and comfort, driving innovation for affordable contact lenses.

相关内容

Materials for Medical Devices Manufacturing | Sigma-Aldrich

This capabilities video explores our Contract manufacturing (CMO) expertise including our global supply chain, ISO 13485 manufacturing sites, quality systems and regulatory guidance for clinical device and IVD production.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门